Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10435369 Tricyclic sulfones as ROR gamma modulators

Patent 10435369 was granted and assigned to Bristol-Myers Squibb on October, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+70 characters)
Article

Patent abstract

There are described RORγ modulators of the formula (I),

Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 20 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 20 Mar, 2023
Edits on 7 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
0
Edits on 8 Oct, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
0
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104353690
Date of Patent
October 8, 2019
0
Patent Application Number
158065540
Date Filed
November 8, 2017
0
Patent Citations Received
‌
US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
0
‌
US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
0
Patent Primary Examiner
‌
Matthew P Coughlin
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
Edits on 9 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
Edits on 29 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10435369 Tricyclic sulfones as ROR gamma modulators

Infobox
Is a
Patent
Patent
Patent applicant
Bristol-Myers Squibb
Bristol-Myers Squibb
Current assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10435369
Date of patent
October 8, 2019
Patent application number
15806554
Date Filed
November 8, 2017
Patent primary examiner
‌
Matthew P Coughlin

Find more entities like US Patent 10435369 Tricyclic sulfones as ROR gamma modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo